StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

Equities research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Down 3.1 %

Retractable Technologies stock opened at $0.82 on Friday. The firm has a market capitalization of $24.55 million, a PE ratio of -1.52 and a beta of 1.96. The company’s 50-day moving average is $0.76 and its 200-day moving average is $0.77. Retractable Technologies has a fifty-two week low of $0.56 and a fifty-two week high of $1.33. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. PFG Investments LLC acquired a new position in Retractable Technologies in the 3rd quarter valued at about $27,000. Renaissance Technologies LLC grew its stake in Retractable Technologies by 9.4% in the 4th quarter. Renaissance Technologies LLC now owns 361,253 shares of the company’s stock valued at $249,000 after buying an additional 31,140 shares during the last quarter. Finally, Wealthfront Advisers LLC acquired a new position in Retractable Technologies in the 4th quarter valued at about $1,748,000. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.